Source:http://linkedlifedata.com/resource/pubmed/id/9827930
General Info
Affiliation
Division of Medical Oncology A, Istituto Nazionale Tumori, Milan, Italy.Abstract
Twenty-six patients with relapsed or refractory Hodgkin's disease (HD) were treated with an intensive salvage regimen combining ifosfamide (3000 mg/m2/d, days 1-4 through continuous intravenous infusion) and vinorelbine (25 mg/m2, i.v. days 1 and 5) with mesna uroprotection and G-CSF support. Courses were given at 3-week intervals. Ten patients achieved a complete and 10 patients a partial response, yielding an overall response rate of 77%. The main toxic effect was neutropenia and the combination was well tolerated.
PMID
9827930
Publication types
Clinical Trial